Last reviewed · How we verify
NCT03330925
Safety and Feasibility of the ElastiMed's SACS
NA trial testing ElastiMed's SACS in Compression; Vein in 11 participants. Completed in 3 December 2018.
3 December 2018
Quick facts
| Lead sponsor | ElastiMed ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 11 |
| Start date | 24 January 2018 |
| Primary completion | 3 December 2018 |
| Estimated completion | 3 December 2018 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- ElastiMed's SACS
Conditions studied
- Compression; Vein — all drugs for Compression; Vein →
Sponsor
ElastiMed ltd
Who can join
Adults 18 to 70, any sex, with Compression; Vein. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to demonstrate the safety and the feasibility of this device, and its ability to increase venous blood flow Primary safety Endpoint: To demonstrate the safety of the device- no serious adverse effect Primary feasibility Endpoint: Increase the blood flow velocity The blood flow will be detected by a Duplex Ultrasonography test at the popliteal vein and the femoral vein. The volunteers will rest at controlled environment room . Measurements will be performed after 30 min of rest without the device on the leg (baseline) and after 30 min of device activity .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03330925
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03330925 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ElastiMed ltd
- Last refreshed: 6 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03330925.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing